EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reply to Jiang et al., “Validating meropenem forecasts for the next dose during CRRT”

Adrian Valadez, Marc H Scheetz iD, Michael N Neely iD, Nathaniel J Rhodes iD

Antimicrobial Agents and Chemotherapy · 10.11.2026

DOI: 10.1128/aac.01289-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 10.11.2026. Verfasst von Adrian Valadez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Midwestern University, College of Pharmacy, Downers Grove, Illinois, USA. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Midwestern University, National Institute of Allergy and Infectious Diseases.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Midwestern University, College of Pharmacy, Downers Grove, Illinois, USA.
  • Pharmacometrics Center of Excellence, Midwestern University, Downers Grove, Illinois, USA.
  • Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.
  • Department of Pharmacology, College of Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.
  • Department of Biomedical Sciences, College of Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.
  • Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Marc H Scheetz, Michael N Neely, Nathaniel J Rhodes

Förderung

  • Midwestern University
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Valadez, A., Scheetz, M. H., Neely, M. N., & Rhodes, N. J. (2026). Reply to Jiang et al., “Validating meropenem forecasts for the next dose during CRRT”. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01289-26

Vancouver

Valadez A, Scheetz MH, Neely MN, Rhodes NJ. Reply to Jiang et al., “Validating meropenem forecasts for the next dose during CRRT”. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01289-26

BibTeX
@article{Valadez2026,
  author = {Valadez, Adrian and Scheetz, Marc H and Neely, Michael N and Rhodes, Nathaniel J},
  title = {Reply to Jiang et al., “Validating meropenem forecasts for the next dose during CRRT”},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01289-26}
}
Kostenlos starten →